World COVID-19 in Argentina: A shortage of vaccines threatens second injections
Biden agreed to waive vaccine patents. But will that help get doses out faster?
Vaccinating the world will be tough. Here’s what intellectual property waivers can and can’t do.The reversal came as Covid-19 deaths are mounting in India and elsewhere. The vaccination program in the US is going well, but much of the world is still waiting for vaccines, which has made the role of pharmaceutical companies and intellectual property in the global vaccine effort the subject of intense debate.
Argentina, which has just passed the symbolic bar of the three million cases of Covid-19, also has difficulty being delivered the vaccines it has bought. India, new epicenter of the pandemic, could not deliver in March the second part of the 1,160,000 doses of the Cobishield vaccine ordered. Result: Thousands of Argentines who received the first dose of this serum do not know if they can receive the second.
The world could be doing much more to help India
Countries can’t go it alone in tackling Covid-19.Now, there are so many people with severe Covid-19 that health care workers like him in several cities have to make difficult decisions about which patients to move to the ICU, who gets put on a ventilator, whom to give oxygen — if those options are even available.
with our correspondent in Buenos Aires, Conscience
Sylvia Baschuk is 74 years old. She lives in Villa Ventana, in the province of Buenos Aires. On March 1st, this doctor and her husband received their first dose of the: "We had an appointment on March 29 to receive the second dose, but we no longer have any news.
No news, because India, which produces the Covishield vaccine, suspended deliveries. However, the maximum period of twelve weeks between the two injections will eventually arrive at the end of May for the vast majority of some 500,000 Argentines who received a dose of this vaccine. "I feel blurred, worried, angry, but especially blushed," says Sylvia Baschuk.Losing the benefits of the first Injection
Constanza Flores Vidal is all the more worried that it is his 80-year-old mother, who has heavy medical history, who could lose the benefits of his first injection: "yesterday. Yesterday Just my mother was worried and asked me, "When will it end? I am losing the little time that stays me! " She does not see us a lot, she can not see her children or grandchildren. She can not have a normal life of an 80-year-old lady, and we are all very anxious.
People who received a CovisciLed injection may optionally complete with a dose of Astrazeneca, which has the same formula. But to date, Argentina has not received any 22 million doses purchased from the Swedo-British group.
► to read:
India's second coronavirus wave causing global 'crisis' as COVID-19 vaccine supplies disrupted .
The global vaccine supply chain, already under extreme pressure, has been thrown into disarray by the COVID-19 crisis devastating India. India is the world's biggest manufacturer of COVID-19 vaccines, and the Serum Institute of India had been earmarked to produce a third of the global supply of the AstraZeneca vaccine in 2021.As India's healthcare system collapses under the second wave of infections, the Indian government has virtually halted vaccine exports, instead keeping supplies onshore to inoculate its own population.